HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, cilt.56, sa.2, ss.125-130, 2018 (ESCI)
Aim: Tigecycline has been approved by the Food and Drug Administration for the treatment of complicated intra-abdominal infections, skin and soft tissue infections and community-acquired pneumonia. In our study, we examined the efficacy of tigecycline in clinical practice and reported real life data from our hospital over a period of five years.